C reactive protein and acute phase of ischaemic strokeBMJ 2001; 322 doi: https://doi.org/10.1136/bmj.322.7302.1605/a (Published 30 June 2001) Cite this as: BMJ 2001;322:1605
- Mario Di Napoli, consultant neurologist ([email protected])
- Department of Neurology and Neurorehabilitation, Casa di Cura Villa Pini d'Abruzzo, 661080 Chieti, Italy
EDITOR—Higher C reactive protein concentrations indicate increased risk of coronary and cerebrovascular events in otherwise healthy individuals1 and a worse prognosis in myocardial infarction2 and ischaemic stroke.3 According to Pepys and Berger, the available data support its potential role as a marker of cardiovascular risk.4 To be of clinical use, however, the protein must have an independent prognostic value over and above that of the data already routinely available.
In patients with acute myocardial infarction or ischaemic stroke the extent of …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial